Platelet activating factor-induced clinical and histopathologic responses in atopic skin and their modification by the platelet activating factor antagonist BN52063
- 31 August 1990
- journal article
- clinical trial
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 23 (2) , 263-268
- https://doi.org/10.1016/0190-9622(90)70210-9
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Effect of BN 52021, a platelet activating factor antagonist, on experimental murine contact dermatitisBritish Journal of Dermatology, 1988
- ACCUMULATION OF EOSINOPHILS IN RESPONSE TO INTRACUTANEOUS PAF-ACETHER AND ALLERGENS IN MANThe Lancet, 1986
- PAF-acether specific binding sites: 2. Design of specific antagonistsTrends in Pharmacological Sciences, 1986
- Association of Platelet-Activating Factor with Primary Acquired Cold UrticariaNew England Journal of Medicine, 1985
- Structural identification of platelet activating factor in psoriatic scaleBiochemical and Biophysical Research Communications, 1985
- Platelet‐activating factor: a possible mediator of the dual response to allergen?Clinical and Experimental Allergy, 1984
- Inflammatory characteristics of platelet activating factor (PAF-acether) in human skinBritish Journal of Dermatology, 1984
- Effect of synthetic PAF-acether on human neutrophil functionInflammation Research, 1981
- Patterns of mast cell alterations and in vivo mediator release in human allergic skin reactionsJournal of Allergy and Clinical Immunology, 1980
- The chloroacetate esterase reactionThe American Journal of Dermatopathology, 1979